Weight change in the management of youth-onset type 2 diabetes: the TODAY clinical trial experience

BACKGROUND: The Treatment Options for type 2 Diabetes in Adolescents and Youth (TODAY) clinical trial documented that metformin plus rosiglitazone, but not metformin plus lifestyle intervention, provided superior durability of glycemic control relative to metformin monotherapy. OBJECTIVES: We examin...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Pediatr Obes
Main Authors: Marcus, M. D., Wilfley, D. E., El ghormli, L., Zeitler, P., Linder, B., Hirst, K., Ievers-Landis, C. E., van Buren, D. J., Walders-Abramson, N.
Format: Artigo
Jezik:Inglês
Izdano: 2016
Teme:
Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC5209292/
https://ncbi.nlm.nih.gov/pubmed/27161901
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/ijpo.12148
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki